With this in mind, we explored the potential of PO, which was previously shown to inhibit TBX2 and TBX3 in TBX2‐/3‐dependant melanoma and rhabdomyosarcoma cells, to inhibit levels of these two proteins in PDAC cells. Here, PRB4 is linked to rhabdomyosarcoma.